Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Lloydspharmacy boss steps down after three years in role

The CEO of McKesson UK – Lloydspharmacy’s and AAH’s parent company – Toby Anderson has stepped down from the the role with “immediate effect”, the company has announced. 

Mr Anderson leaves the company after almost four years as CEO, McKesson UK announced today (May 11).

Private equity firm Aurelius Group completed the acquisition of McKesson UK last month (April 7).

Commenting on Mr Anderson’s time at McKesson, Dominik Müser - who works within Aurelius's leadership team - said the company is “extremely grateful for the commitment Toby has demonstrated over the years to help us achieve the McKesson vision of becoming the UK’s leading healthcare organisation”.

“His leadership, during a period of great uncertainty, has given us the solid foundations we can now build on to deliver sustained success in the future,” Mr Müser added.

During the COVID -19 pandemic, Mr Anderson “ensured that our customers and patients could continue to receive the vital medicines and services they needed”, Mr Müser said.

He also commended Mr Anderson’s work in helping “turn around the profitability of our business”.

“We remain focussed on delivering great services for our customers and patients across our individual businesses. Through our core businesses – Lloydspharmacy, Lloydspharmacy Clinical Homecare, and AAH – we play a vital role in protecting the health of communities across the country and we have an exciting opportunity to grow and improve our businesses even more over the next few years,” Mr Müser added.

 

Read more: Lloyds CEO ‘implores’ government to reimburse pharmacy business rates

 

In a message to McKesson UK employees, seen by C+D, Mr Anderson confirmed he was stepping down as, “as part of the McKesson’s strategy to divest the European businesses, including the UK and the subsequent purchase by Aurelius, [the] whole strategy is to accelerate clearer and more direct accountability of and within our business units”.

Mr Anderson went on to thank his executive team and “all colleagues across the McKesson UK organisation, who have shown great courage and commitment in supporting our customers, patients and continuing to deliver vital services during the last couple of years, while the country has faced into the pandemic”.

“I would like to wish everyone at McKesson UK best wishes for the future, and to take this opportunity to say goodbye,” he added. 

Read more: Lloyds chief: The ‘great pain’ of deciding to close Lloyds branches

 

Related Content

Topics


         
Pharmacist
Bermuda
£85,500 per annum

Apply Now
UsernamePublicRestriction

Register

CD136105

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel